VP, Global Product Dev, NeuroScience

The Neuroscience leadership role requires proven abilities to drive both strategic innovation and measurable business outcomes. The incumbent’s track record of therapeutic expertise will be extensive and ensure recognition of the incumbent as a peer of their Pharmaceutical Industry equivalents. This position will play a key part in the future business success of PPD as it seeks to continue its track record of successful growth and expand its Industry leading position

The role comprises four major functions:

First, the incumbent is responsible for ensuring the highest possible quality of input into significant requests for proposals (RFPs) including: Development strategy and regulatory issues Drug class issues Protocol and indication considerations, including safety Team education on indication Interactions with client physicians and/or client Neuroscience leaders prior to or during bid defenses Identifying business opportunities for PPD

Secondly, the incumbent is responsible for supporting outstanding input into other areas of PPD’s business activity including: Pro-active client engagement: peer-to-peer interaction with Neuroscience leaders and senior medical directors of companies whose product portfolio contains drugs of business interest to PPD Strategic alliance development & support Client governance or advisory boards Through PPD’s consulting practice, the incumbent will provide Industry gold standard product development plans, and top level design of clinical trial protocols that are required in the plan

Thirdly, the incumbent will provide a supporting role in PPD’s Neuroscience Therapeutic Area Strategic Team (TAST), a cross functional team charged with championing PPD’s business development by creating focused solutions for client companies. Examples of activities related to the development of these integrated business offerings to client companies include: Identifying strategic client opportunities Client pipeline analysis Identifying drug product opportunities Partner with business development to implement specific strategies to grow therapeutic area book of business Evaluating and integrating PPD’s service offerings, such as Phase 1 first in human testing capabilities Clinical trial operations expertise Regulatory intelligence expertise Laboratory capabilities (including biomarkers) Imaging capabilities Post-approval studies and outcomes expertise Special services – i.e. DSMB management, ARO partnership

Fourthly, the incumbent will be responsible for providing therapeutic and developmental expertise to internal PPD teams including: Indication-specific training for clinical teams Guidance during clinical trial execution Clinical data review and evaluation Investigator brochure, clinical study report, NDA/MAA documents, and regulatory briefing documents review and editing Contribute to design and reporting of feasibility studies Liaise with investigators and KOLs Mentor and supervise Neuroscience clinical scientists

The Neuroscience leadership role requires proven abilities to drive both strategic innovation and measurable business outcomes. The incumbent’s track record of therapeutic expertise will be extensive and ensure recognition of the incumbent as a peer of their Pharmaceutical Industry equivalents. This position will play a key part in the future business success of PPD as it seeks to continue its track record of successful growth and expand its Industry leading position

The role comprises four major functions:

First, the incumbent is responsible for ensuring the highest possible quality of input into significant requests for proposals (RFPs) including: Development strategy and regulatory issues Drug class issues Protocol and indication considerations, including safety Team education on indication Interactions with client physicians and/or client Neuroscience leaders prior to or during bid defenses Identifying business opportunities for PPD

Secondly, the incumbent is responsible for supporting outstanding input into other areas of PPD’s business activity including: Pro-active client engagement: peer-to-peer interaction with Neuroscience leaders and senior medical directors of companies whose product portfolio contains drugs of business interest to PPD Strategic alliance development & support Client governance or advisory boards Through PPD’s consulting practice, the incumbent will provide Industry gold standard product development plans, and top level design of clinical trial protocols that are required in the plan

Thirdly, the incumbent will provide a supporting role in PPD’s Neuroscience Therapeutic Area Strategic Team (TAST), a cross functional team charged with championing PPD’s business development by creating focused solutions for client companies. Examples of activities related to the development of these integrated business offerings to client companies include: Identifying strategic client opportunities Client pipeline analysis Identifying drug product opportunities Partner with business development to implement specific strategies to grow therapeutic area book of business Evaluating and integrating PPD’s service offerings, such as Phase 1 first in human testing capabilities Clinical trial operations expertise Regulatory intelligence expertise Laboratory capabilities (including biomarkers) Imaging capabilities Post-approval studies and outcomes expertise Special services – i.e. DSMB management, ARO partnership

Fourthly, the incumbent will be responsible for providing therapeutic and developmental expertise to internal PPD teams including: Indication-specific training for clinical teams Guidance during clinical trial execution Clinical data review and evaluation Investigator brochure, clinical study report, NDA/MAA documents, and regulatory briefing documents review and editing Contribute to design and reporting of feasibility studies Liaise with investigators and KOLs Mentor and supervise Neuroscience clinical scientists

Education and Experience: MD or equivalent with experience implementing Neuroscience therapeutic programs (i.e., neurology, psychiatry and/or pain) Significant experience contributing to product development team activities from early development through marketing application and/or launch to include 7 years of pharmaceutical industry experience. Experience overseeing the design and execution of at least one full clinical program from first-time-in-human or proof of concept studies through submission of marketing application. Direct experience with the creation and implementation of full asset development including pre-clinical, clinical, regulatory, CMC and (if applicable) biomarker strategy development.

Knowledge, Skills and Abilities: Thorough understanding of overall biologic/pharmaceutical product development process, from pre-clinical through post-marketing, including all stages of development and all functional roles Experience developing strategies to support first-time-in-human studies through marketing application Therapeutic and indication-specific development expertise across one or more therapeutic areas and one or more drug classes, including deep knowledge of clinical program and study design, relevant endpoints, safety considerations, and current regulatory and commercial landscape. Thorough understanding of core cross-functional concepts (e.g., preclinical, translational medicine, CMC) and major program requirements at different development stages Deep knowledge of important regulatory considerations and experience with FDA, EMA and other national regulatory authorities Experience as a medical strategy leader on one or more asset development teams Experience with KOL and investigator interactions Strong decision-making and analytical skills Excellent communication and influencing skills Excellent organizational skills and detail-orientated leadership approach Flexibility to travel domestically and internationally Ability to work independently on multiple tasks in a fast-paced environment

Education and Experience: MD or equivalent with experience implementing Neuroscience therapeutic programs (i.e., neurology, psychiatry and/or pain) Significant experience contributing to product development team activities from early development through marketing application and/or launch to include 7 years of pharmaceutical industry experience. Experience overseeing the design and execution of at least one full clinical program from first-time-in-human or proof of concept studies through submission of marketing application. Direct experience with the creation and implementation of full asset development including pre-clinical, clinical, regulatory, CMC and (if applicable) biomarker strategy development.

Knowledge, Skills and Abilities: Thorough understanding of overall biologic/pharmaceutical product development process, from pre-clinical through post-marketing, including all stages of development and all functional roles Experience developing strategies to support first-time-in-human studies through marketing application Therapeutic and indication-specific development expertise across one or more therapeutic areas and one or more drug classes, including deep knowledge of clinical program and study design, relevant endpoints, safety considerations, and current regulatory and commercial landscape. Thorough understanding of core cross-functional concepts (e.g., preclinical, translational medicine, CMC) and major program requirements at different development stages Deep knowledge of important regulatory considerations and experience with FDA, EMA and other national regulatory authorities Experience as a medical strategy leader on one or more asset development teams Experience with KOL and investigator interactions Strong decision-making and analytical skills Excellent communication and influencing skills Excellent organizational skills and detail-orientated leadership approach Flexibility to travel domestically and internationally Ability to work independently on multiple tasks in a fast-paced environment